How chemical blisters break down skin cell attachments
Coordinated cytoskeletal and cell adhesion dynamics in vesicant induced skin injury
This project looks at how blister-causing chemicals damage the way skin cells stick together so future treatments can prevent severe blistering and scarring.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11248424 on NIH RePORTER |
What this research studies
You should know that scientists are studying how blister-causing chemicals change the way skin cells hold together and how their internal skeletons behave. They will use lab-grown human skin models and genetically altered mice to follow key proteins such as ACF7 and the enzyme FAK that help cells attach and remodel. By mapping these molecular steps and how they fail after chemical exposure, researchers aim to identify points where drugs or therapies could stop or reduce blistering and disfigurement. Most of the work is done in laboratory models and is intended to guide future medical countermeasures rather than testing treatments in people right away.
Who could benefit from this research
Good fit: People who have experienced skin injury from vesicant (blister) chemicals or who are at high risk of such exposure would be the most relevant group for future clinical efforts based on this work.
Not a fit: Patients with common non-chemical skin problems (for example, eczema or psoriasis) or inherited blistering disorders may not benefit directly from findings specific to chemical vesicant injury.
Why it matters
Potential benefit: If successful, this work could point to new treatments that limit skin blistering, scarring, and long-term disability after exposure to chemical blister agents.
How similar studies have performed: Earlier laboratory studies, including prior work by this team, show that ACF7 and FAK influence cell adhesion, but applying that knowledge specifically to chemical blister prevention is relatively new.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Wu, Xiaoyang — University of Chicago
- Study coordinator: Wu, Xiaoyang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.